Navigation Links
Shares Of AVI BioPharma Drops On Reports Of Disappointing Early Drug Trail

Shares of AVI BioPharma Inc. has lost a third of their value on Wednesday after the company reported disappointing clinical trial data for its experimental treatment against the hepatitis C virus. //

The shares of AVI were down $2.43, or 33 percent, to $4.83, in the heavy morning trade on the Nasdaq.

The Portland, Oregon based biotechnology company said that the results came from the second stage of a trial involving the antisense drug, called AVI-4065, among patients infected with the liver-damaging virus. Company officials have said that the drug showed favourable safety in all patients treated so far, but patients have experienced only a mean "slight decrease" in the amount of virus in their bloodstreams both during and after treatment.

In a press release the company officials said that during the 14 days of treatment, three of five patients evaluated had an initial decrease in viral load, whereas two of five exhibited little initial change. They were quick to point out that the results were still only preliminary and in only a small number of patients, and that patients remained enrolled in the study. They stated that the formal results of the trial were expected around the end of the year.

Antisense drugs, like AVI-4065, are artificial pieces of genetic material that are meant to prevent genes from expressing disease-causing proteins. Sadly the technology has not yet achieved great success despite high earlier hopes.


'"/>




Page: 1

Related medicine news :

1. ViroPharma Shares Fall As FDA Moves Towards Generic Vancocin
2. Sun Pharma Allots Shares Upon Fccbs Conversion
3. Zenotech Issues 20 Lakh Shares to Ranbaxy for Rs 20 Cr
4. Female Ratio Drops Alarmingly In Himachal Due To Feticides
5. 1.8 mn Delhi Children to Receive Anti-polio Drops
6. Antibiotic Ear Drops Favored Over Oral Antibiotics for Ear Infections
7. No Smoking During Play Rehearsals: UK’s Health Ministry Drops the Curtain
8. Russia Reports First SARS Case
9. Uganda Reports Failure To Contain Sleeping Sickness
10. Reports of Hantavirus infection in India raise concerns
11. Controversy Surrounding The HIV Positive Reports Of One-Year Girl In Kerala
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... On June ... sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, ... of the city’s history as home to some of the world’s leading providers of ...
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
(Date:6/24/2016)... 24, 2016   Bay Area Lyme Foundation ... Dean Center for Tick Borne Illness , Harvard ... MIT Hacking Medicine, University of California, Berkeley, and ... the five finalists of Lyme Innovation , ... than 100 scientists, clinicians, researchers, entrepreneurs, and investors ...
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June 24, 2016 ... mobile pulmonary function testing company, is now able to perform sophisticated ... by ndd Medical Technologies , Inc. Patients ... hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ARL patients ... get any needed testing done in the comfort of her own ...
Breaking Medicine Technology: